Sunday, April 20, 2014

* A newly approved Hepatitis C drug (Sovaldi) is on pace to record among the highest sales ever for a newly approved first year drug.

* Sovaldi promises to cure 90% of its targeted patients, who would likely develop liver cancer or need a liver transplant if untreated.

* Liver transplants cost $175,000.

* Sovaldi's list price is $84,000 for a 12-week supply ($1000 per day).

* Sovaldi is projected to do between $5 billion and $9 billion in sales this year.

* Humira was last years biggest selling drug with $10.7 billion in world wide sales.


* Source - WSJ

No comments:

Post a Comment